Vantage Investment Advisors’s Boston Scientific BSX Stock Holding History

Vantage Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$115K	Buy	2,989 +1,350	+82%	+$47.2K	0.02%	201
2018 Q2	$54K	Hold	1,639	–	–	0.01%	264
2018 Q1	$45K	Sell	1,639 -1,482	-47%	-$40.3K	0.01%	298
2017 Q4	$77K	Sell	3,121 -2,270	-42%	-$62.6K	0.02%	240
2017 Q3	$157K	Hold	5,391	–	–	0.04%	156
2017 Q2	$149K	Hold	5,391	–	–	0.04%	147
2017 Q1	$134K	Hold	5,391	–	–	0.04%	150
2016 Q4	$117K	Hold	5,391	–	–	0.05%	156
2016 Q3	$128K	Buy	5,391 +3,752	+229%	+$89.5K	0.06%	139
2016 Q2	$38K	Hold	1,639	–	–	0.02%	300
2016 Q1	$31K	Hold	1,639	–	–	0.01%	318
2015 Q4	$30K	Hold	1,639	–	–	0.02%	311
2015 Q3	$27K	Hold	1,639	–	–	0.02%	316
2015 Q2	$29K	Sell	1,639 -1,639	-50%	-$29.3K	0.02%	315
2015 Q1	$58K	Buy	3,278 +1,639	+100%	+$25.9K	0.02%	312
2014 Q4	$22K	Hold	1,639	–	–	0.01%	355
2014 Q3	$19K	Hold	1,639	–	–	0.01%	367
2014 Q2	$21K	Hold	1,639	–	–	0.01%	363
2014 Q1	$22K	Hold	1,639	–	–	0.01%	323
2013 Q4	$20K	Buy	+1,639	New	+$19.4K	0.01%	324

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Vantage Investment Advisors's BSX Position: Q3 2018 in Review

Vantage Investment Advisors increased its Boston Scientific (BSX) stake by 82% in Q3 2018, buying an estimated $47.2K and bringing the position to 2,989 shares worth $115K. The position accounts for 0.02% of the portfolio, ranked #201.

Vantage Investment Advisors first reported a position in BSX in Q4 2013 and has held it in 20 quarters since. The position peaked at $157K in Q3 2017. 699 funds tracked by Wall St. Rank hold BSX as of Q3 2018.

Vantage Investment Advisors held 2,989 shares of Boston Scientific worth $115K as of Q3 2018.
Vantage Investment Advisors bought 1,350 Boston Scientific shares in Q3 2018, an estimated $47.2K.
Boston Scientific made up 0.02% of Vantage Investment Advisors's portfolio in Q3 2018, its #201 holding.
Vantage Investment Advisors first reported a position in Boston Scientific in Q4 2013 and has held it in 20 quarters since.
Vantage Investment Advisors's Boston Scientific position peaked at $157K in Q3 2017.
699 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.